April 8, 2016—The Health Resources and Services Administration has taken another step toward amending the 340B Pharmaceutical Pricing Agreement to include drug manufacturer program integrity provisions in the Affordable Care Act.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)